Wagner, John A.

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 1,163

Wearable devices in clinical trials: hype and hypothesis

Izmailova, E. S., Wagner, J. A., & Perakslis, E. D. (2018) · Clinical Pharmacology & Therapeutics

Mobile Health and mHealth ApplicationsStatistical Methods in Clinical Trials

Cited by 265

Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults

Gantz, I., Erondu, N., Mallick, M., Musser, B., Krishna, R., Tanaka, W. K., Snyder, K., Stevens, C., Stroh, M. A., Zhu, H., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 163

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects

Thomas, T., Zhou, H., Karmally, W., Ramakrishnan, R., Holleran, S., Liu, Y., Jumes, P., Wagner, J. A., Hubbard, B., Previs, S. F., et al. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 96

Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

Godfrey, A., Vandendriessche, B., Bakker, J. P., Fitzer‐Attas, C., Gujar, N., Hobbs, M., Liu, Q., Northcott, C. A., Parks, V., Wood, W. A., et al. (2021) · Clinical and Translational Science

Healthcare Technology and Patient MonitoringNon-Invasive Vital Sign Monitoring

Cited by 60

Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

Van Laere, K., De Hoon, J., Bormans, G., Koole, M., Derdelinckx, I., De Lepeleire, I., Declercq, R., Sanabria Bohorquez, S. M., Hamill, T., Mozley, P. D., et al. (2012) · Clinical Pharmacology & Therapeutics

Nausea and vomiting managementPharmacogenetics and Drug Metabolism

Cited by 46

Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development

Wagner, J. A., Dahlem, A. M., Hudson, L. D., Terry, S. F., Altman, R. B., Gilliland, C. T., DeFeo, C., & Austin, C. P. (2018) · Clinical and Translational Science

Health and Medical Research ImpactsInterdisciplinary Research and Collaboration

Cited by 45

Regulatory Pathways for Qualification and Acceptance of Digital Health Technology‐Derived Clinical Trial Endpoints: Considerations for Sponsors

Bakker, J. P., Izmailova, E. S., Clement, A., Hoffmann, S., Leptak, C., Menetski, J. P., & Wagner, J. A. (2025) · Clinical Pharmacology & Therapeutics

Statistical Methods in Clinical TrialsMobile Health and mHealth Applications

Cited by 26

Accelerating Parkinson’s Disease drug development with federated learning approaches

Khanna, A., Adams, J., Antoniades, C., Bloem, B. R., Carroll, C., Cedarbaum, J., Cosman, J., Dexter, D. T., Dockendorf, M. F., Edgerton, J., et al. (2024) · npj Parkinson's Disease

Privacy-Preserving Technologies in DataParkinson's Disease Mechanisms and Treatments

Cited by 21